SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	Jul 12, 2023	View HTML 0001562180-23-005881.pdf 0001562180-23-005881.rtf 0001562180-23-005881.xls
4	Statement of changes in beneficial ownership of securities	Jul 12, 2023	View HTML 0001562180-23-005880.pdf 0001562180-23-005880.rtf 0001562180-23-005880.xls
8-K	Report of unscheduled material events or corporate event	Jul 11, 2023	View HTML 0000950170-23-032444.pdf 0000950170-23-032444.rtf 0000950170-23-032444.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
8-K	Report of unscheduled material events or corporate event	Jul 10, 2023	View HTML 0000950170-23-032324.pdf 0000950170-23-032324.rtf 0000950170-23-032324.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
4	Statement of changes in beneficial ownership of securities	Jun 26, 2023	View HTML 0001562180-23-005502.pdf 0001562180-23-005502.rtf 0001562180-23-005502.xls
4	Statement of changes in beneficial ownership of securities	Jun 22, 2023	View HTML 0001562180-23-005441.pdf 0001562180-23-005441.rtf 0001562180-23-005441.xls
4	Statement of changes in beneficial ownership of securities	Jun 22, 2023	View HTML 0001562180-23-005440.pdf 0001562180-23-005440.rtf 0001562180-23-005440.xls
4	Statement of changes in beneficial ownership of securities	Jun 22, 2023	View HTML 0001562180-23-005443.pdf 0001562180-23-005443.rtf 0001562180-23-005443.xls
4	Statement of changes in beneficial ownership of securities	Jun 22, 2023	View HTML 0001562180-23-005444.pdf 0001562180-23-005444.rtf 0001562180-23-005444.xls
4	Statement of changes in beneficial ownership of securities	Jun 22, 2023	View HTML 0001562180-23-005442.pdf 0001562180-23-005442.rtf 0001562180-23-005442.xls

Data provided by Kaleidoscope.